retatrutide phase 2 trial obesity nejm 2023 triple agonist Incretin (LY3437943) alleviates obesity-associated cancer progression retatrutide triple agonist glp-1 gip

D-Psicose increases energy expenditure and decreases body fat accumulation in rats fed a high-sucrose diet

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus

Sleeve plus procedures: This involves performing a sleeve surgery and adding a bypass to the sleeve to enhance its effectiveness Each surgery has its own benefits and risks, so its important to choose the right one based on personal needs and medical advice

Pharmacological modulation of nitric oxide release: new pharmacological perspectives, potential benefits and risks

The numbers in cells indicate the number of genes found and the entries in bracket are uniprot ids (for Annotated genes) and (GI ids for RPS-Blast results)

The peptide's therapeutic potential extends beyond mere neuroprotection to actual neural repair and regeneration